{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "16282880", "DateCompleted": {"Year": "2006", "Month": "07", "Day": "19"}, "DateRevised": {"Year": "2023", "Month": "05", "Day": "19"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "1076-2752", "JournalIssue": {"Volume": "47", "Issue": "11", "PubDate": {"Year": "2005", "Month": "Nov"}}, "Title": "Journal of occupational and environmental medicine", "ISOAbbreviation": "J Occup Environ Med"}, "ArticleTitle": "Nasal effects of a mixture of volatile organic compounds and their ozone oxidation products.", "Pagination": {"StartPage": "1182", "EndPage": "1189", "MedlinePgn": "1182-9"}, "Abstract": {"AbstractText": ["Our objective was to determine if low levels of a mixture of volatile organic compounds (VOCs) and their ozone (O3) oxidation products, similar to what might be found in \"sick buildings,\" cause nasal irritation and inflammation under controlled exposure conditions.", "Healthy, nonsmoking women (n=130) completed 2-hour controlled exposures to VOCs, VOCs and O3, and a masked air \"MA\" control in random order at least 1 week apart. VOCs and O3 concentrations were approximately 25 mg/m and approximately 40 ppb, respectively. Nasal symptoms were rated before, during, and after exposure. Nasal lavage fluid was analyzed for polymorphonuclear cells, total protein, interleukin-6, and interleukin-8.", "We found no significant differences in symptoms or markers of nasal inflammation between exposure conditions.", "Results suggest that VOCs and their oxidation products may not cause acute nasal effects at low concentrations."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Environmental and Occupational Health Sciences Institute, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA. laumbach@eohsi.rutgers.edu"}], "Identifier": [], "LastName": "Laumbach", "ForeName": "Robert J", "Initials": "RJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Fiedler", "ForeName": "Nancy", "Initials": "N"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Gardner", "ForeName": "Carol R", "Initials": "CR"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Laskin", "ForeName": "Debra L", "Initials": "DL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Fan", "ForeName": "Zhi-Hua", "Initials": "ZH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhang", "ForeName": "Junfeng", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Weschler", "ForeName": "Charles J", "Initials": "CJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lioy", "ForeName": "Paul J", "Initials": "PJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Devlin", "ForeName": "Robert B", "Initials": "RB"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ohman-Strickland", "ForeName": "Pamela", "Initials": "P"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kelly-McNeil", "ForeName": "Kathie", "Initials": "K"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kipen", "ForeName": "Howard M", "Initials": "HM"}], "GrantList": [{"GrantID": "P30 ES005022", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "R01 ES004738", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Occup Environ Med", "NlmUniqueID": "9504688", "ISSNLinking": "1076-2752"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Organic Chemicals"}, {"RegistryNumber": "0", "NameOfSubstance": "Oxidants, Photochemical"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Air Pollution, Indoor"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Nasal Lavage Fluid"}, {"QualifierName": ["physiopathology"], "DescriptorName": "Nasal Mucosa"}, {"QualifierName": [], "DescriptorName": "Odds Ratio"}, {"QualifierName": ["adverse effects", "chemistry"], "DescriptorName": "Organic Chemicals"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Oxidants, Photochemical"}, {"QualifierName": ["adverse effects", "chemistry"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Volatilization"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2005", "Month": "11", "Day": "12", "Hour": "9", "Minute": "0"}, {"Year": "2006", "Month": "7", "Day": "20", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "11", "Day": "12", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["16282880", "10.1097/01.jom.0000183338.95778.f0", "00043764-200511000-00012"]}}], "PubmedBookArticle": []}